✦ LIBER ✦
881 COMBINATION THERAPY WITH EGFR1–2/VEGFR INHIBITOR (XL647) AND SORAFENIB IMPROVES OUTCOMES IN A PRE-CLINICAL MODEL OF HCC
✍ Scribed by B. Mínguez; S. Toffanin; A. Lachenmayer; L. Cabellos; A. Villanueva; A. DiFeo; P. Melgar-Lesmes; S. Thung; S.L. Friedman; J.M. Llovet
- Book ID
- 117378962
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 71 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.